Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tacrolimus/Sirolimus vs Tacrolimus/MMF vs Neoral/Sirolimus in Kidney Transplants
NCT00681213Phase 4Completed
- Sponsor
- University of Miami
- Start
- May 2000
- Primary completion
- Dec 2001
- Modality
- Peptides, RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in kidney transplantation comparing Tacrolimus/Sirolimus, Tacrolimus/MMF and Neoral/Sirolimus (3 arms). Primary endpoint: Incidence and severity of acute rejection episodes at 1 year. Started May 2000; status: completed.
02
Drugs
tacrolimussirolimusmycophenolate mofetilcyclosporine
03
Conditions
kidney transplantation
Beyond the preview
Go deeper on NCT00681213.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00681213.